GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sihuan Pharmaceutical Holdings Group Ltd (HKSE:00460) » Definitions » 5-Year Yield-on-Cost %

Sihuan Pharmaceutical Holdings Group (HKSE:00460) 5-Year Yield-on-Cost % : 10.07 (As of Jun. 20, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sihuan Pharmaceutical Holdings Group 5-Year Yield-on-Cost %?

Sihuan Pharmaceutical Holdings Group's yield on cost for the quarter that ended in Dec. 2023 was 10.07.


The historical rank and industry rank for Sihuan Pharmaceutical Holdings Group's 5-Year Yield-on-Cost % or its related term are showing as below:

HKSE:00460' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.63   Med: 2.45   Max: 10.46
Current: 10.07


During the past 13 years, Sihuan Pharmaceutical Holdings Group's highest Yield on Cost was 10.46. The lowest was 0.63. And the median was 2.45.


HKSE:00460's 5-Year Yield-on-Cost % is ranked better than
91.34% of 508 companies
in the Drug Manufacturers industry
Industry Median: 2.27 vs HKSE:00460: 10.07

Competitive Comparison of Sihuan Pharmaceutical Holdings Group's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sihuan Pharmaceutical Holdings Group's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's 5-Year Yield-on-Cost % falls into.



Sihuan Pharmaceutical Holdings Group 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Sihuan Pharmaceutical Holdings Group is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Sihuan Pharmaceutical Holdings Group  (HKSE:00460) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Sihuan Pharmaceutical Holdings Group 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Sihuan Pharmaceutical Holdings Group's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sihuan Pharmaceutical Holdings Group (HKSE:00460) Business Description

Traded in Other Exchanges
Address
Zhubang 2000 Business Centre, 22nd Floor, Building 4, West Balizhuang, Chaoyang District, Beijing, CHN, 100025
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Digestive System, Anti-Infective, metabolism, Respiratory, Neurology, and Others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others to provide non- or minimally invasive medical aesthetics comprehensive solutions; the innovative medicine and other medicine segments; and the generic medicine segment.
Executives
Che Fengsheng 2201 Interest of corporation controlled by you
Guo Weicheng 2201 Interest of corporation controlled by you
Meng Xianhui 2201 Interest of corporation controlled by you
Zhang Jionglong 2201 Interest of corporation controlled by you
Mingyao Capital Limited 2401 A concert party to an agreement to buy shares
Network Victory Limited 2401 A concert party to an agreement to buy shares
Proper Process International Limited 2401 A concert party to an agreement to buy shares
Successmax Global Holdings Limited 2101 Beneficial owner
Victory Faith International Limited 2401 A concert party to an agreement to buy shares
Ubs Tc (jersey) Ltd 2301 Trustee
Ubs Trustees (cayman) Ltd. 2301 Trustee
Smart Top Overseas Limited 2501 Other
Plenty Gold Enterprises Limited 2307 Founder of a discretionary trust who can infl

Sihuan Pharmaceutical Holdings Group (HKSE:00460) Headlines

No Headlines